Shanghai HeartCare to Present at ICCD2025: Design and Technological Evolution of Intracranial Thrombus Aspiration Catheters
HeartCare
Neurointerventional Medical Device Developer
ICCD2025 The 4th Cardiovascular and Cerebrovascular Device Conference will be grandly held in Wuxi on March 19-20!It is a great honor to invite Mr. Xue Zongyu, General Manager of Shanghai HeartCare Medical Technology Co., Ltd., to share at this year's conference.：Design and Evolution of Innovative Technologies for Intracranial Thrombus Aspiration Catheters.
Scan the code to register for the conference.
Vice President of Technology & Quality Regulations at HeartCare, with over 16 years of experience in the medical device industry, possessing extensive expertise in medical device R&D and quality management.
Shanghai HeartCare Medical Technology Co., Ltd. (Stock Code: 06609.HK) was founded in 2016. The company focuses on the unmet clinical needs of doctors and patients in China, and is committed to improving the accessibility of medical innovation technologies and products, reducing mortality from major diseases, improving patient outcomes, and safeguarding life and health. Currently, HeartCare has pioneered a one-stop solution for stroke treatment and prevention in the field of neurointervention. Its product pipeline covers neurointerventional treatment devices for thrombectomy, aneurysms, and stenosis, interventional access devices, as well as stroke prevention devices. The company holds 31 product registration certificates for medical devices produced in China, owns over 200 authorized patents, and two of its products have received "Priority Review for Innovative Devices" status. Its sales channels cover all provincial administrative regions in China except Hong Kong and Macao, and its products are used in nearly 2,000 stroke centers.
